Condition: Breast Cancer · Radiotherapy Side Effect · Sponsor: Institute of Oncology Ljubljana
The purpose of this study is to identify potential genetic and other molecular biomarkers of response to radiation therapy in breast cancer that may help to personalize breast cancer radiation treatment in the future.
This description comes directly from the study's public registry record.
Tanja Marinko, MD, PhD · 0038615879505 · tmarinko@onko-i.si
Always discuss trial participation with your own doctor first.
| Institute of Oncology Ljubljana | Ljubljana, Slovenia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06648148